ENGLEWOOD, Colo.--(BUSINESS WIRE)-- Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced further expansion of its ...

ENGLEWOOD, Colo.--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that the U.S.

Shares of Paragon 28, Inc. (NYSE: FNA) rose 1.3% to close at $16.66 on Wednesday after the medical device company revealed that the U.S. Food and Drug Administration (FDA) has given 501(k) marketing ...

Potential role for PKA-dependent HIF-1α stabilization at the interface of hypoxia and inflammation. HIF stabilization during hypoxic or ischemic tissue conditions can dampen hypoxia-driven ...

The importance of understanding the role of proteins in diseases—as drugs, drug targets, and biomarkers—has increased remarkably in recent years. In fact, it is now undeniably clear that proteins play ...